Riskpilot← Back to searchSign inGet full accessShahyad Medic AB
ABActiveOrg 5591216352StockholmMedical specialists activities · NACE 8622Est. 20170 employees
Revenue 2025
SEK 360K
+29% vs 2024
EBITDA margin
57.6%
+54% vs 2024
Equity ratio
91.1%
Financial strength
Net profit 2025
SEK 108K
+69% vs 2024
| Revenue | SEK 360K | +29% |
| EBITDA | SEK 207K | +54% |
| Net profit | SEK 108K | +69% |
| Total assets | SEK 715K | +20% |
| Equity | SEK 651K | +20% |
| Employees | 0 | — |
Legal name
Shahyad Medic AB
Org number
5591216352
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 augusti 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget skall bedriva konsultverksamhet och erbjuda läkarkompetens inom medicinsk verksamhet, med fokus på akutsjukvård samt därmed förenlig verksamhet. Även import och export av medicinsk utrustning kan förekomma. Aktiebolaget skall även bedriva verksamhet genom föreläsningar inom ämnet medicin, kriminologi samt statsvetenskap samt författarskap och därmed förenlig verksamhet.
Address
Stockholm
Email
pd2fjsac8@kivramail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 450 | 159 | 200 | 279 | 360 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 377 | 2 | 26 | 134 | 207 |
| Depreciation & amort. | −1 | −18 | −20 | −56 | −73 |
| EBIT | 376 | −16 | 6 | 78 | 135 |
| Net financials | — | — | 2 | 3 | 1 |
| Profit before tax | 377 | −16 | 8 | 81 | 136 |
| Tax | −78 | — | — | −17 | −28 |
| Net profit | 299 | −16 | 8 | 64 | 108 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 690 | 555 | 490 | 595 | 715 |
| Equity | 486 | 470 | 479 | 543 | 651 |
| Long-term debt | 0 | 4 | 4 | 29 | 29 |
| Short-term debt | 204 | 80 | 7 | 24 | 35 |
| Total debt | 204 | 84 | 11 | 52 | 63 |
EBITDA margin
57.6%
This company
15.8%
Market median
+265% vs market
20212025
Equity ratio
91.1%
This company
38.2%
Market median
+138% vs market
20212025
Return on equity
16.7%
This company
18.4%
Market median
+9% vs market
20212025
Net profit margin
30.1%
This company
8.1%
Market median
+272% vs market
20212025
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AM Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Shahyad Medic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ardavan M Khoshnood | Chief Executive Officer | 0 companies |
| Arvin Khoshnood | Deputy Board Member | 0 companies |